Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Special MTA: Probes for Oncology Posters

  • You have access
    Pretargeted dual-modality (SPECT/fluorescence) imaging in a carcinoembryonic antigen-expressing tumor model
    Mark Rijpkema, Robert Sharkey, Desiree Bos, Bill McBride, Wim Oyen, David Goldenberg and Otto Boerman
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1154;
  • You have access
    Indigenous development of a single vial kit preparation of 99mTc-doxorubicin and its preclinical evaluation
    Pardeep Kumar, Baljinder Singh, Shalini Chopra, Krishna Chuttani, Anil Mishra and Bhagwant Mittal
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1126;
  • You have access
    99mTc-Duramycin imaging of high-dose ionizing irradiation-induced tissue injuries
    Steven Johnson, Zhixin Li, John Moulder and Ming Zhao
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1134;
  • You have access
    Development of NOTA/DOTA cyclo-RGD dimers labelled with Ga-68 for cancer diagnosis and therapy follow-up
    Dana Niculae, Filip Daniel Puicea, Ioana Esanu, Valentina Negoita and Diana Savu
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1131;
  • You have access
    Improved Sumitomo CFN multifunction module synthesis FDG with Beijing PET reagent kit
    Min Yan, Si-jin Li and Zhi-fang Wu
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1127;
  • You have access
    dPEG®ylation of 124I-labeled mCC49Fab'-NEM improves tumor imaging in mice
    Michael Tweedle, Haiming Ding, Michelle Carleton, Keisha Milum, Krishan Kumar, Shankaran Kothandaraman, George Hinkle, Richard Brody, Alexander Pokora and Edward Martin
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1150;
  • You have access
    Ex vivo evaluation of Cu-64-TP3805 for imaging prostate cancer
    Sushil Tripathi, Kaijun Zhang, Sushil Tripathi, Chaitra Channappa, Peter McCue and Edouard Trabulsi
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1158;
  • You have access
    A PET compatible tumor bioreactor (TBR) for imaging research
    Timothy Whitehead, Samuel Nemanich, Sudheer Rani, Carmen Dence, Nicole Fettig and Kooresh Shoghi
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1132;
  • You have access
    Radioiodinated inhibitors of cathepsin B as tumor imaging probes
    Patricia Edem, Shannon Czorny and John Valliant
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1135;
  • You have access
    64Cu-labeled GRPR agonist and antagonist in prostate cancer PET imaging
    Veronique Dumulon-Perreault, Samia Ait-Mohand, Lidia Matei, Patrick Fournier, Jean-Francois Beaudoin, Francois Benard and Brigitte Guerin
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1155;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
SNMMI

© 2025 SNMMI

Powered by HighWire